Tounjian Advisory Partners, LLC Gilead Sciences, Inc. Transaction History
Tounjian Advisory Partners, LLC
- $534 Billion
- Q1 2025
A detailed history of Tounjian Advisory Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tounjian Advisory Partners, LLC holds 3,782 shares of GILD stock, worth $388,827. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,782Holding current value
$388,827% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,177Shares Held
989MCall Options Held
8.72MPut Options Held
9.39M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$11.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.37 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.21 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$5.96 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $129B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...